Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q88947288 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000115.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q88947288 | ||
| 024 | ‡a 0000-0002-6895-0024 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q88947288 | ||
| 100 | 0 | ‡a Kai Li ‡c researcher (ORCID 0000-0002-6895-0024) ‡9 en | |
| 670 | ‡a Author's Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling | ||
| 670 | ‡a Author's Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling | ||
| 670 | ‡a Author's CD31-labeled circulating endothelial cells as predictor in anlotinib-treated non-small-cell lung cancer: Analysis on ALTER-0303 study. | ||
| 670 | ‡a Author's Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients | ||
| 670 | ‡a Author's Effect of anlotinib as a third- or further-line therapy in advanced non-small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial | ||
| 670 | ‡a Author's Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer | ||
| 909 | ‡a (orcid) 0000000268950024 ‡9 1 | ||
| 919 | ‡a bevacizumabpromotesactivebiologicalbehaviorsofhumanumbilicalveinendothelialcellsbyactivatingtgfβ1pathwaysviaoffvegfsignaling ‡A Bevacizumab promotes active biological behaviors of human umbilical vein endothelial cells by activating TGFβ1 pathways via off-VEGF signaling ‡9 1 | ||
| 919 | ‡a tumornecrosisfactorsuperfamily15promoteslymphaticmetastasisviaupregulationofvascularendothelialgrowthfactor100inamousemodeloflungcancer ‡A Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer ‡9 1 | ||
| 919 | ‡a clinicalimportanceofvegfcandpdl1coexpressioninlungadenocarcinomapatients ‡A Clinical importance of VEGFC and PD-L1 co-expression in lung adenocarcinoma patients ‡9 1 | ||
| 919 | ‡a anlotinibsuppresseslymphangiogenesisandlymphaticmetastasisinlungadenocarcinomathroughaprocesspotentiallyinvolvingvegfr3signaling ‡A Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling ‡9 1 | ||
| 919 | ‡a effectofanlotinibasa3orfurtherlinetherapyinadvancednonsmallcelllungcancerpatientswithdifferenthistologictypessubgroupanalysisinthealter0303trial ‡A Effect of anlotinib as a third- or further-line therapy in advanced non-small cell lung cancer patients with different histologic types: Subgroup analysis in the ALTER0303 trial ‡9 1 | ||
| 919 | ‡a cd31labeledcirculatingendothelialcellsaspredictorinanlotinibtreatednonsmallcelllungcanceranalysisonalter0303study ‡A CD31-labeled circulating endothelial cells as predictor in anlotinib-treated non-small-cell lung cancer: Analysis on ALTER-0303 study. ‡9 1 | ||
| 996 | ‡2 ISNI|0000000041243173 | ||
| 996 | ‡2 NII|DA07624263 | ||
| 996 | ‡2 BIBSYS|8003930 | ||
| 996 | ‡2 ISNI|0000000064156080 | ||
| 996 | ‡2 DNB|102282337X | ||
| 996 | ‡2 ISNI|0000000032698870 | ||
| 996 | ‡2 ISNI|0000000064008811 | ||
| 996 | ‡2 RERO|A012512384 | ||
| 996 | ‡2 LC|nr 88010260 | ||
| 996 | ‡2 ISNI|0000000063735830 | ||
| 996 | ‡2 LC|nr 99015413 | ||
| 996 | ‡2 J9U|987007429077405171 | ||
| 996 | ‡2 LC|nr 96037275 | ||
| 996 | ‡2 LC|n 92804752 | ||
| 996 | ‡2 DNB|1032932872 | ||
| 996 | ‡2 SZ|1079850317 | ||
| 996 | ‡2 LC|no2010098955 | ||
| 996 | ‡2 ISNI|000000050175678X | ||
| 996 | ‡2 ISNI|0000000063566651 | ||
| 996 | ‡2 DNB|1250261651 | ||
| 996 | ‡2 ISNI|0000000064085630 | ||
| 996 | ‡2 DNB|1332427693 | ||
| 996 | ‡2 LC|n 88074943 | ||
| 996 | ‡2 ISNI|0000000064111675 | ||
| 996 | ‡2 ISNI|0000000114534909 | ||
| 996 | ‡2 LC|no 93004000 | ||
| 996 | ‡2 DNB|173683363 | ||
| 996 | ‡2 DNB|1262344816 | ||
| 996 | ‡2 LC|n 90718859 | ||
| 996 | ‡2 ISNI|0000000064282810 | ||
| 996 | ‡2 CYT|AC000217558 | ||
| 996 | ‡2 ISNI|0000000071443897 | ||
| 996 | ‡2 NTA|150656769 | ||
| 996 | ‡2 RERO|A003518944 | ||
| 996 | ‡2 J9U|987007343487505171 | ||
| 996 | ‡2 ISNI|000000006335232X | ||
| 996 | ‡2 PLWABN|9810638820205606 | ||
| 996 | ‡2 ISNI|0000000083996376 | ||
| 996 | ‡2 LC|nr 93008416 | ||
| 996 | ‡2 N6I|vtls000335482 | ||
| 996 | ‡2 J9U|987007424704605171 | ||
| 996 | ‡2 ISNI|0000000064254115 | ||
| 996 | ‡2 LC|n 83005656 | ||
| 996 | ‡2 ISNI|0000000063538204 | ||
| 996 | ‡2 NTA|245941495 | ||
| 996 | ‡2 LC|n 88241291 | ||
| 996 | ‡2 DNB|1089416318 | ||
| 996 | ‡2 DNB|1204881375 | ||
| 996 | ‡2 ISNI|0000000063761609 | ||
| 996 | ‡2 KRNLK|KAC200707598 | ||
| 996 | ‡2 LC|n 2007087789 | ||
| 996 | ‡2 ISNI|0000000418613358 | ||
| 996 | ‡2 PLWABN|9810605985305606 | ||
| 996 | ‡2 SUDOC|119476827 | ||
| 996 | ‡2 BNF|12424954 | ||
| 996 | ‡2 DNB|133564355 | ||
| 996 | ‡2 ISNI|0000000039233961 | ||
| 996 | ‡2 SUDOC|16470275X | ||
| 996 | ‡2 DNB|117844287X | ||
| 996 | ‡2 NSK|000594260 | ||
| 996 | ‡2 CYT|AC000662902 | ||
| 996 | ‡2 CYT|AC000643269 | ||
| 996 | ‡2 ISNI|0000000080450001 | ||
| 996 | ‡2 KRNLK|KAC200801990 | ||
| 996 | ‡2 ISNI|000000006343259X | ||
| 996 | ‡2 SUDOC|242138314 | ||
| 996 | ‡2 CYT|AC000217560 | ||
| 996 | ‡2 NII|DA04245371 | ||
| 996 | ‡2 NSK|000677274 | ||
| 996 | ‡2 LC|n 2008019557 | ||
| 996 | ‡2 CAOONL|ncf11658977 | ||
| 996 | ‡2 DNB|1295100150 | ||
| 996 | ‡2 CYT|AC000441879 | ||
| 996 | ‡2 ISNI|0000000080290626 | ||
| 996 | ‡2 LC|n 2023183987 | ||
| 996 | ‡2 ISNI|0000000116485805 | ||
| 996 | ‡2 ISNI|0000000114724040 | ||
| 996 | ‡2 DNB|1319578411 | ||
| 996 | ‡2 DNB|1200237749 | ||
| 996 | ‡2 NTA|101889682 | ||
| 996 | ‡2 CYT|AC000632981 | ||
| 996 | ‡2 ISNI|000000006375728X | ||
| 996 | ‡2 SUDOC|085863688 | ||
| 996 | ‡2 RERO|A012432307 | ||
| 996 | ‡2 SUDOC|137764383 | ||
| 996 | ‡2 CYT|AC000636241 | ||
| 996 | ‡2 LC|n 82047383 | ||
| 996 | ‡2 DNB|1054091684 | ||
| 996 | ‡2 BIBSYS|90879698 | ||
| 996 | ‡2 ISNI|0000000085010662 | ||
| 996 | ‡2 ISNI|0000000381636838 | ||
| 996 | ‡2 LC|nr 88004863 | ||
| 996 | ‡2 NTA|303746319 | ||
| 996 | ‡2 ISNI|0000000063286414 | ||
| 996 | ‡2 ISNI|0000000064344882 | ||
| 996 | ‡2 DNB|1228637539 | ||
| 996 | ‡2 ISNI|000000006336841X | ||
| 996 | ‡2 ISNI|0000000063428267 | ||
| 996 | ‡2 ISNI|0000000077316186 | ||
| 996 | ‡2 BIBSYS|90380057 | ||
| 996 | ‡2 NDL|031399575 | ||
| 996 | ‡2 NTA|303980966 | ||
| 996 | ‡2 LC|n 98027235 | ||
| 996 | ‡2 ISNI|0000000377399729 | ||
| 996 | ‡2 CYT|AC000639172 | ||
| 996 | ‡2 BIBSYS|7000759 | ||
| 996 | ‡2 ISNI|0000000100237815 | ||
| 996 | ‡2 NUKAT|n 2019067871 | ||
| 996 | ‡2 DNB|141836407 | ||
| 996 | ‡2 ISNI|0000000083848728 | ||
| 996 | ‡2 LC|nr 96009347 | ||
| 996 | ‡2 ISNI|0000000110455293 | ||
| 996 | ‡2 ISNI|0000000071151835 | ||
| 996 | ‡2 DNB|1260980219 | ||
| 996 | ‡2 J9U|987007451247905171 | ||
| 996 | ‡2 DNB|1275500986 | ||
| 996 | ‡2 LC|no2012103035 | ||
| 996 | ‡2 LC|n 2006031316 | ||
| 996 | ‡2 DNB|1122231113 | ||
| 996 | ‡2 DNB|1266106642 | ||
| 996 | ‡2 DNB|1200448898 | ||
| 996 | ‡2 LC|no2018043406 | ||
| 996 | ‡2 CYT|AC000639549 | ||
| 996 | ‡2 LC|nr2001015996 | ||
| 996 | ‡2 LC|no2003041671 | ||
| 996 | ‡2 JPG|500288157 | ||
| 996 | ‡2 ISNI|0000000063830010 | ||
| 996 | ‡2 ISNI|0000000063883331 | ||
| 996 | ‡2 LC|n 78022415 | ||
| 996 | ‡2 ISNI|0000000082066230 | ||
| 996 | ‡2 LC|no2022062717 | ||
| 996 | ‡2 ISNI|0000000499223086 | ||
| 996 | ‡2 RERO|A006053609 | ||
| 996 | ‡2 ISNI|0000000064158027 | ||
| 996 | ‡2 ISNI|0000000064365800 | ||
| 996 | ‡2 DNB|1035043513 | ||
| 996 | ‡2 ISNI|0000000082892380 | ||
| 996 | ‡2 DNB|1310589739 | ||
| 996 | ‡2 PTBNP|1903745 | ||
| 996 | ‡2 DNB|1025268539 | ||
| 996 | ‡2 ISNI|0000000064240434 | ||
| 996 | ‡2 LC|nr 90000493 | ||
| 996 | ‡2 CAOONL|ncf10246671 | ||
| 996 | ‡2 BIBSYS|5090348 | ||
| 996 | ‡2 LC|n 80095035 | ||
| 996 | ‡2 LC|n 85146771 | ||
| 996 | ‡2 LC|no2013092950 | ||
| 996 | ‡2 LC|nr 94030835 | ||
| 996 | ‡2 LC|n 88231879 | ||
| 996 | ‡2 CYT|AC000217562 | ||
| 996 | ‡2 BIBSYS|3037759 | ||
| 996 | ‡2 DNB|1262986893 | ||
| 996 | ‡2 ISNI|0000000066607981 | ||
| 996 | ‡2 ISNI|0000000063780412 | ||
| 996 | ‡2 LC|n 2018001703 | ||
| 996 | ‡2 ISNI|0000000053856575 | ||
| 996 | ‡2 NTA|36418292X | ||
| 996 | ‡2 LC|no2018131697 | ||
| 996 | ‡2 SUDOC|111750512 | ||
| 996 | ‡2 LC|n 2009060366 | ||
| 996 | ‡2 J9U|987007281259105171 | ||
| 996 | ‡2 NTA|298803895 | ||
| 996 | ‡2 ISNI|0000000382872875 | ||
| 996 | ‡2 ISNI|0000000063965206 | ||
| 996 | ‡2 BNF|15590101 | ||
| 996 | ‡2 NTA|191857203 | ||
| 996 | ‡2 ISNI|0000000079846228 | ||
| 996 | ‡2 ISNI|000000038817367X | ||
| 996 | ‡2 ISNI|0000000063530675 | ||
| 996 | ‡2 LC|n 2007013832 | ||
| 996 | ‡2 BIBSYS|17441 | ||
| 996 | ‡2 BIBSYS|15034286 | ||
| 996 | ‡2 ISNI|0000000071281875 | ||
| 996 | ‡2 LC|n 2018067994 | ||
| 996 | ‡2 ISNI|0000000063355694 | ||
| 996 | ‡2 ISNI|0000000499610959 | ||
| 996 | ‡2 BNF|16067864 | ||
| 996 | ‡2 ISNI|000000038262808X | ||
| 996 | ‡2 PLWABN|9813136380605606 | ||
| 996 | ‡2 ISNI|0000000398612322 | ||
| 996 | ‡2 ISNI|0000000047142787 | ||
| 996 | ‡2 DNB|1079850317 | ||
| 996 | ‡2 SZ|1310589739 | ||
| 996 | ‡2 LC|nr 90028127 | ||
| 996 | ‡2 LC|n 87910720 | ||
| 996 | ‡2 DNB|1168744717 | ||
| 996 | ‡2 LC|nr 97039230 | ||
| 996 | ‡2 ISNI|0000000063152301 | ||
| 996 | ‡2 SUDOC|104530197 | ||
| 996 | ‡2 ISNI|0000000381728708 | ||
| 996 | ‡2 ISNI|0000000064367822 | ||
| 996 | ‡2 J9U|987007413112705171 | ||
| 996 | ‡2 SUDOC|191484652 | ||
| 996 | ‡2 BNF|16149026 | ||
| 996 | ‡2 DNB|1158861079 | ||
| 996 | ‡2 DNB|1249957745 | ||
| 996 | ‡2 DNB|1077523475 | ||
| 996 | ‡2 LC|n 89134931 | ||
| 996 | ‡2 LC|no 96030085 | ||
| 996 | ‡2 CYT|AC000216814 | ||
| 996 | ‡2 LC|nr 95025554 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
